127 related articles for article (PubMed ID: 34837908)
21. Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Noda Y; Fujita H; Bae KT
Eur J Radiol; 2015 May; 84(5):811-5. PubMed ID: 25650331
[TBL] [Abstract][Full Text] [Related]
22. Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with β-catenin and bone mineral density.
Ma C; Shuai B; Shen L; Yang YP; Xu XJ; Li CG
Osteoporos Int; 2016 Apr; 27(4):1529-1535. PubMed ID: 26572758
[TBL] [Abstract][Full Text] [Related]
23. Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study.
Su WW; Lee KT; Yeh YT; Soon MS; Wang CL; Yu ML; Wang SN
J Clin Lab Anal; 2010; 24(3):195-200. PubMed ID: 20486202
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
25. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY; Cohen SM; Lim JK
Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
[TBL] [Abstract][Full Text] [Related]
26. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.
Liu C; Jia BS; Zou BW; Du H; Yan LN; Yang JY; Jiang L; Wen TF; Lu WS
Medicine (Baltimore); 2017 Nov; 96(45):e8512. PubMed ID: 29137051
[TBL] [Abstract][Full Text] [Related]
28. CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma.
Zhu J; Yang Y; Ma C; Zhang G; Wang K; Hu S
World J Surg; 2011 Oct; 35(10):2259-65. PubMed ID: 21519971
[TBL] [Abstract][Full Text] [Related]
29. The promoting effect of adiponectin in hepatocellular carcinoma.
Chen MJ; Yeh YT; Lee KT; Tsai CJ; Lee HH; Wang SN
J Surg Oncol; 2012 Aug; 106(2):181-7. PubMed ID: 22287480
[TBL] [Abstract][Full Text] [Related]
30. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.
Kiriyama S; Yokoyama S; Ueno M; Hayami S; Ieda J; Yamamoto N; Yamaguchi S; Mitani Y; Nakamura Y; Tani M; Mishra L; Shively JE; Yamaue H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S505-14. PubMed ID: 24390710
[TBL] [Abstract][Full Text] [Related]
31. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
32. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
[TBL] [Abstract][Full Text] [Related]
33. Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma.
Ram AK; Pottakat B; Vairappan B
BMC Cancer; 2018 May; 18(1):572. PubMed ID: 29776350
[TBL] [Abstract][Full Text] [Related]
34. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
Li X; Xu H; Gao P
Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
[TBL] [Abstract][Full Text] [Related]
35. Cryoprotective therapy for huge hepatocellular carcinoma: a study of 14 patients with a single lesion.
Alnaggar M; Niu L; Li J; Yao F; Wang Y; Zeng J; Ye J; Chen J; Mu F; Xu K
Cryobiology; 2014 Dec; 69(3):457-61. PubMed ID: 25445461
[TBL] [Abstract][Full Text] [Related]
36. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma.
Cruz PV; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K
Cancer; 2005 Jul; 104(2):354-60. PubMed ID: 15952183
[TBL] [Abstract][Full Text] [Related]
37. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
39. Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients.
Tang T; Qiu JL; Li GW; Huang MP; Li Y; Li YJ; Gu SZ
Clin Radiol; 2018 Mar; 73(3):259-265. PubMed ID: 29032942
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
